Basics PERRIGO COMPANY PLC Perrigo Co PLC is a healthcare company providing branded OTC products throughout Europe and the USA. It sells its products primarily in North America and Europe, as well as in other markets, including Australia, Israel and China. IPO Date: December 17, 1991 Sector: Healthcare Industry: Pharma Market Cap: $1.85B Activated in VL: True Average Daily Range Avg Daily Range: $0.73 | 1.24% Avg Daily Range (30 D): $0.32 | 2.04% Avg Daily Range (90 D): $0.34 | 1.70% Institutional Daily Volume Avg Daily Volume: 1.06M Avg Daily Volume (30 D): 3.22M Avg Daily Volume (90 D): 2.1M Trade Size Avg Trade Size (Sh.): 106 Avg Trade Size (Sh.) (30 D): 92 Avg Trade Size (Sh.) (90 D): 81 Institutional Trades Total Inst.Trades: 17,561 Avg Inst. Trade: $3.54M Avg Inst. Trade (30 D): $3.68M Avg Inst. Trade (90 D): $3.33M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 3 Market Closing Trades Avg Closing Trade: $6.9M Avg Closing Trade (30 D): $8.35M Avg Closing Trade (90 D): $7.06M Avg Closing Volume: 119.41K     News Dec 8, 2025 @ 8:01 AM PRGO Investors Have Opportunity to Lead Perrigo Co... Source: Prnewswire Dec 6, 2025 @ 9:19 PM ROSEN, A RANKED AND LEADING FIRM, Encourages Perri... Source: Rosen Law Firm Dec 6, 2025 @ 2:50 PM PRGO INVESTOR ALERT: Robbins Geller Rudman & Dowd ... Source: Robbins Geller Rudman & Dowd Llp Dec 5, 2025 @ 5:00 PM DEADLINE ALERT for FCX, PRGO, STUB: Law Offices of... Source: Law Offices Of Howard G. Smith Nov 28, 2025 @ 4:46 PM Bragar Eagel & Squire, P.C. Reminds Investors That... Source: Bragar Eagel & Squire, P.C. Financials   TTM Q2 2025 Q1 2025 Basic EPS $.05 $-.06 $-.05 Diluted EPS $.05 $-.06 $-.05 Revenue $ 1.04B $ 1.06B $ 1.04B Gross Profit $ 377.1M $ 362.9M $ 392.3M Net Income / Loss $ 7.5M $ -8.4M $ -6.4M Operating Income / Loss $ 72.6M $ 45.4M $ 46.9M Cost of Revenue $ 666.2M $ 693.4M $ 651.6M Net Cash Flow $ -20M $ 7.8M $ -141.7M PE Ratio 265.10